Anti-VEGF Treatment for Prevention of PDR/DME

NCT02634333 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

399

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy
Diabetic Macular Edema

Interventions

PROCEDURE: Prompt Sham
DRUG: Prompt aflibercept
PROCEDURE: Deferred laser
DRUG: Deferred aflibercept

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]